acrylamide has been researched along with Follicular Thyroid Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andry, G; Caillet-Fauquet, P; Chico Galdo, V; Dequanter, D; Friedman, M; Jin, L; Lothaire, P; Massart, C; Van Sande, J; Vanvooren, V | 1 |
1 other study(ies) available for acrylamide and Follicular Thyroid Carcinoma
Article | Year |
---|---|
Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures.
Topics: Acrylamide; Adenocarcinoma, Follicular; Animals; Carcinogenicity Tests; Cell Culture Techniques; Cell Line; Cells, Cultured; Colforsin; Comet Assay; Cyclic AMP; DNA Damage; Dogs; Dose-Response Relationship, Drug; Epoxy Compounds; Humans; Hydrogen Peroxide; Rats; Sheep; Thyroid Gland; Thyroid Neoplasms; Thyrotropin | 2006 |